AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal, Co., Inc. (NASDAQ:HITK) announced today that it has entered into an agreement with Victory Pharma, Inc. to market Naprelan® in the United States. Naprelan® extended release tablets is a non-steroidal anti-inflammatory, licensed by Hi-Tech from Élan Pharmaceuticals, Inc. Victory, based in San Diego, CA, will promote Naprelan® directly to physicians through its sales and marketing force. Hi-Tech concurrently terminated the marketing and distribution agreement with Blansett Pharmacal, its previous marketing partner.
